Indegene Limited has informed the Exchange regarding allotment of 69596 shares under ESOP 2020 Plan.
INDGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indegene Limited reported its Q1 FY26 (quarter ended June 30, 2025) results, with consolidated revenue from operations at Rs 7,608 million, up about 12.5% from Rs 6,765 million in the same quarter last year. Consolidated profit after tax rose nearly 33% year-on-year to Rs 1,164 million, lifting basic EPS to Rs 4.86 (vs Rs 3.79 a year ago). On a standalone basis, revenue was Rs 2,556 million and profit after tax was Rs 451 million. The board also approved allotment of 69,596 shares under the ESOP 2020 Plan, and a final dividend of Rs 2 per share for FY25 was paid on June 30, 2025. Auditor Deloitte Haskins & Sells issued an unmodified review opinion on the results.
Solid double-digit revenue growth and a strong jump in profits point to healthy operating momentum, which is positive for shareholders. The ESOP allotment is routine and creates only a very small dilution, with no material effect on shareholding.